img

Global Oligonucleotide Therapeutics Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oligonucleotide Therapeutics Drug Market Insights, Forecast to 2034

Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
Market Analysis and InsightsGlobal Oligonucleotide Therapeutics Drug Market
Global Oligonucleotide Therapeutics Drug market is expected to reach to US$ 352 million in 2024, with a positive growth of %, compared with US$ 325 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Oligonucleotide Therapeutics Drug industry is evaluated to reach US$ 499.3 million in 2029. The CAGR will be 6.0% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Oligonucleotide Therapeutics Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oligonucleotide Therapeutics Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Biogen
Sarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics
Segment by Type
Antisense Oligonucleotide
Aptamer
Other

Segment by Application


Neuromuscular Diseases
ATTR
Hepatic VOD
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Oligonucleotide Therapeutics Drug introduction, etc. Oligonucleotide Therapeutics Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Oligonucleotide Therapeutics Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide Therapeutics Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antisense Oligonucleotide
1.2.3 Aptamer
1.2.4 Other
1.3 Market by Application
1.3.1 Global Oligonucleotide Therapeutics Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Neuromuscular Diseases
1.3.3 ATTR
1.3.4 Hepatic VOD
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Therapeutics Drug Market Perspective (2018-2029)
2.2 Global Oligonucleotide Therapeutics Drug Growth Trends by Region
2.2.1 Oligonucleotide Therapeutics Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oligonucleotide Therapeutics Drug Historic Market Size by Region (2018-2024)
2.2.3 Oligonucleotide Therapeutics Drug Forecasted Market Size by Region (2024-2029)
2.3 Oligonucleotide Therapeutics Drug Market Dynamics
2.3.1 Oligonucleotide Therapeutics Drug Industry Trends
2.3.2 Oligonucleotide Therapeutics Drug Market Drivers
2.3.3 Oligonucleotide Therapeutics Drug Market Challenges
2.3.4 Oligonucleotide Therapeutics Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oligonucleotide Therapeutics Drug by Players
3.1.1 Global Oligonucleotide Therapeutics Drug Revenue by Players (2018-2024)
3.1.2 Global Oligonucleotide Therapeutics Drug Revenue Market Share by Players (2018-2024)
3.2 Global Oligonucleotide Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oligonucleotide Therapeutics Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Oligonucleotide Therapeutics Drug Market Concentration Ratio
3.4.1 Global Oligonucleotide Therapeutics Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Therapeutics Drug Revenue in 2022
3.5 Global Key Players of Oligonucleotide Therapeutics Drug Head office and Area Served
3.6 Global Key Players of Oligonucleotide Therapeutics Drug, Product and Application
3.7 Global Key Players of Oligonucleotide Therapeutics Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Therapeutics Drug Breakdown Data by Type
4.1 Global Oligonucleotide Therapeutics Drug Historic Market Size by Type (2018-2024)
4.2 Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Type (2024-2029)
5 Oligonucleotide Therapeutics Drug Breakdown Data by Application
5.1 Global Oligonucleotide Therapeutics Drug Historic Market Size by Application (2018-2024)
5.2 Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oligonucleotide Therapeutics Drug Market Size (2018-2029)
6.2 North America Oligonucleotide Therapeutics Drug Market Size by Type
6.2.1 North America Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024)
6.2.2 North America Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029)
6.2.3 North America Oligonucleotide Therapeutics Drug Market Share by Type (2018-2029)
6.3 North America Oligonucleotide Therapeutics Drug Market Size by Application
6.3.1 North America Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024)
6.3.2 North America Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029)
6.3.3 North America Oligonucleotide Therapeutics Drug Market Share by Application (2018-2029)
6.4 North America Oligonucleotide Therapeutics Drug Market Size by Country
6.4.1 North America Oligonucleotide Therapeutics Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024)
6.4.3 North America Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Oligonucleotide Therapeutics Drug Market Size (2018-2029)
7.2 Europe Oligonucleotide Therapeutics Drug Market Size by Type
7.2.1 Europe Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024)
7.2.2 Europe Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029)
7.2.3 Europe Oligonucleotide Therapeutics Drug Market Share by Type (2018-2029)
7.3 Europe Oligonucleotide Therapeutics Drug Market Size by Application
7.3.1 Europe Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024)
7.3.2 Europe Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029)
7.3.3 Europe Oligonucleotide Therapeutics Drug Market Share by Application (2018-2029)
7.4 Europe Oligonucleotide Therapeutics Drug Market Size by Country
7.4.1 Europe Oligonucleotide Therapeutics Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024)
7.4.3 Europe Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oligonucleotide Therapeutics Drug Market Size (2018-2029)
8.2 China Oligonucleotide Therapeutics Drug Market Size by Type
8.2.1 China Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024)
8.2.2 China Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029)
8.2.3 China Oligonucleotide Therapeutics Drug Market Share by Type (2018-2029)
8.3 China Oligonucleotide Therapeutics Drug Market Size by Application
8.3.1 China Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024)
8.3.2 China Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029)
8.3.3 China Oligonucleotide Therapeutics Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oligonucleotide Therapeutics Drug Market Size (2018-2029)
9.2 Asia Oligonucleotide Therapeutics Drug Market Size by Type
9.2.1 Asia Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024)
9.2.2 Asia Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029)
9.2.3 Asia Oligonucleotide Therapeutics Drug Market Share by Type (2018-2029)
9.3 Asia Oligonucleotide Therapeutics Drug Market Size by Application
9.3.1 Asia Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024)
9.3.2 Asia Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029)
9.3.3 Asia Oligonucleotide Therapeutics Drug Market Share by Application (2018-2029)
9.4 Asia Oligonucleotide Therapeutics Drug Market Size by Region
9.4.1 Asia Oligonucleotide Therapeutics Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Oligonucleotide Therapeutics Drug Market Size by Region (2018-2024)
9.4.3 Asia Oligonucleotide Therapeutics Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Oligonucleotide Therapeutics Drug Introduction
11.1.4 Biogen Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.1.5 Biogen Recent Developments
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Drug Introduction
11.2.4 Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.2.5 Sarepta Therapeutics Recent Developments
11.3 Jazz Pharmaceuticals
11.3.1 Jazz Pharmaceuticals Company Details
11.3.2 Jazz Pharmaceuticals Business Overview
11.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Introduction
11.3.4 Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.3.5 Jazz Pharmaceuticals Recent Developments
11.4 Bausch & Lomb
11.4.1 Bausch & Lomb Company Details
11.4.2 Bausch & Lomb Business Overview
11.4.3 Bausch & Lomb Oligonucleotide Therapeutics Drug Introduction
11.4.4 Bausch & Lomb Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.4.5 Bausch & Lomb Recent Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.5.5 Alnylam Pharmaceuticals Recent Developments
11.6 Dynavax Technologies
11.6.1 Dynavax Technologies Company Details
11.6.2 Dynavax Technologies Business Overview
11.6.3 Dynavax Technologies Oligonucleotide Therapeutics Drug Introduction
11.6.4 Dynavax Technologies Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.6.5 Dynavax Technologies Recent Developments
11.7 Kastle therapeutics
11.7.1 Kastle therapeutics Company Details
11.7.2 Kastle therapeutics Business Overview
11.7.3 Kastle therapeutics Oligonucleotide Therapeutics Drug Introduction
11.7.4 Kastle therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.7.5 Kastle therapeutics Recent Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Drug Introduction
11.8.4 Akcea Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.8.5 Akcea Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oligonucleotide Therapeutics Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Antisense Oligonucleotide
Table 3. Key Players of Aptamer
Table 4. Key Players of Other
Table 5. Global Oligonucleotide Therapeutics Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Oligonucleotide Therapeutics Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Oligonucleotide Therapeutics Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Oligonucleotide Therapeutics Drug Market Share by Region (2018-2024)
Table 9. Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Oligonucleotide Therapeutics Drug Market Share by Region (2024-2029)
Table 11. Oligonucleotide Therapeutics Drug Market Trends
Table 12. Oligonucleotide Therapeutics Drug Market Drivers
Table 13. Oligonucleotide Therapeutics Drug Market Challenges
Table 14. Oligonucleotide Therapeutics Drug Market Restraints
Table 15. Global Oligonucleotide Therapeutics Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Oligonucleotide Therapeutics Drug Revenue Share by Players (2018-2024)
Table 17. Global Top Oligonucleotide Therapeutics Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics Drug as of 2022)
Table 18. Global Oligonucleotide Therapeutics Drug Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Oligonucleotide Therapeutics Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Oligonucleotide Therapeutics Drug, Headquarters and Area Served
Table 21. Global Key Players of Oligonucleotide Therapeutics Drug, Product and Application
Table 22. Global Key Players of Oligonucleotide Therapeutics Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Oligonucleotide Therapeutics Drug Revenue Share by Application (2018-2024)
Table 30. Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Oligonucleotide Therapeutics Drug Revenue Share by Application (2024-2029)
Table 32. North America Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Oligonucleotide Therapeutics Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Oligonucleotide Therapeutics Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Oligonucleotide Therapeutics Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Oligonucleotide Therapeutics Drug Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Oligonucleotide Therapeutics Drug Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 64. Biogen Company Details
Table 65. Biogen Business Overview
Table 66. Biogen Oligonucleotide Therapeutics Drug Product
Table 67. Biogen Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 68. Biogen Recent Developments
Table 69. Sarepta Therapeutics Company Details
Table 70. Sarepta Therapeutics Business Overview
Table 71. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Product
Table 72. Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 73. Sarepta Therapeutics Recent Developments
Table 74. Jazz Pharmaceuticals Company Details
Table 75. Jazz Pharmaceuticals Business Overview
Table 76. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Product
Table 77. Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 78. Jazz Pharmaceuticals Recent Developments
Table 79. Bausch & Lomb Company Details
Table 80. Bausch & Lomb Business Overview
Table 81. Bausch & Lomb Oligonucleotide Therapeutics Drug Product
Table 82. Bausch & Lomb Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 83. Bausch & Lomb Recent Developments
Table 84. Alnylam Pharmaceuticals Company Details
Table 85. Alnylam Pharmaceuticals Business Overview
Table 86. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Product
Table 87. Alnylam Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 88. Alnylam Pharmaceuticals Recent Developments
Table 89. Dynavax Technologies Company Details
Table 90. Dynavax Technologies Business Overview
Table 91. Dynavax Technologies Oligonucleotide Therapeutics Drug Product
Table 92. Dynavax Technologies Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 93. Dynavax Technologies Recent Developments
Table 94. Kastle therapeutics Company Details
Table 95. Kastle therapeutics Business Overview
Table 96. Kastle therapeutics Oligonucleotide Therapeutics Drug Product
Table 97. Kastle therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 98. Kastle therapeutics Recent Developments
Table 99. Akcea Therapeutics Company Details
Table 100. Akcea Therapeutics Business Overview
Table 101. Akcea Therapeutics Oligonucleotide Therapeutics Drug Product
Table 102. Akcea Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 103. Akcea Therapeutics Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oligonucleotide Therapeutics Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Oligonucleotide Therapeutics Drug Market Share by Type: 2022 VS 2029
Figure 3. Antisense Oligonucleotide Features
Figure 4. Aptamer Features
Figure 5. Other Features
Figure 6. Global Oligonucleotide Therapeutics Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Oligonucleotide Therapeutics Drug Market Share by Application: 2022 VS 2029
Figure 8. Neuromuscular Diseases Case Studies
Figure 9. ATTR Case Studies
Figure 10. Hepatic VOD Case Studies
Figure 11. Other Case Studies
Figure 12. Oligonucleotide Therapeutics Drug Report Years Considered
Figure 13. Global Oligonucleotide Therapeutics Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Oligonucleotide Therapeutics Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Oligonucleotide Therapeutics Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Oligonucleotide Therapeutics Drug Market Share by Players in 2022
Figure 17. Global Top Oligonucleotide Therapeutics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Oligonucleotide Therapeutics Drug Revenue in 2022
Figure 19. North America Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Oligonucleotide Therapeutics Drug Market Share by Type (2018-2029)
Figure 21. North America Oligonucleotide Therapeutics Drug Market Share by Application (2018-2029)
Figure 22. North America Oligonucleotide Therapeutics Drug Market Share by Country (2018-2029)
Figure 23. United States Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Oligonucleotide Therapeutics Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Oligonucleotide Therapeutics Drug Market Share by Type (2018-2029)
Figure 27. Europe Oligonucleotide Therapeutics Drug Market Share by Application (2018-2029)
Figure 28. Europe Oligonucleotide Therapeutics Drug Market Share by Country (2018-2029)
Figure 29. Germany Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Oligonucleotide Therapeutics Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Oligonucleotide Therapeutics Drug Market Share by Type (2018-2029)
Figure 37. China Oligonucleotide Therapeutics Drug Market Share by Application (2018-2029)
Figure 38. Asia Oligonucleotide Therapeutics Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Oligonucleotide Therapeutics Drug Market Share by Type (2018-2029)
Figure 40. Asia Oligonucleotide Therapeutics Drug Market Share by Application (2018-2029)
Figure 41. Asia Oligonucleotide Therapeutics Drug Market Share by Region (2018-2029)
Figure 42. Japan Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Oligonucleotide Therapeutics Drug Market Share by Country (2018-2029)
Figure 52. Brazil Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Biogen Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 59. Sarepta Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 60. Jazz Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 61. Bausch & Lomb Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 62. Alnylam Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 63. Dynavax Technologies Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 64. Kastle therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 65. Akcea Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries